Form 4 for CLPT ClearPoint Neuro, Inc.
Accepted 2022-06-14 00:00:00 ET · period of report 2022-06-10 · accession 0001285550-22-000022 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-14 | 2022-06-10 | CLPT | D'Alessandro Danilo | CFO | A - Grant | $0.00 | +23.4K | 58.2K | +67% | $0 |
| D | 2022-06-14 | 2022-06-10 | CLPT | D'Alessandro Danilo | CFO | A - Grant | $0.00 | +15.6K | 15.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-10 | A | A | 23,400 | $0.00 | 58,214 | D | — | — | (F1) The shares are restricted stock and vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. (F2) Includes 1,349 shares of common stock acquired through purchases pursuant to the Employee Stock Purchase Plan. |
| 2 | Derivative | Stock Options (right to buy) | 2022-06-10 | A | A | 15,600 | $0.00 | 15,600 | D | $11.41 · — to 2032-06-10 | 15,600 Common Stock | (F3) The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. |